By Benjamin Chiou
Date: Friday 22 Nov 2024
(Sharecast News) - Biopharma giant GSK has announced that Japanese regulators have expanded the approved use of its Arexvy vaccine for severe respiratory syncytial virus (RSV) disease to a wider age range.
By Michele Maatouk
Date: Thursday 21 Nov 2024
(Sharecast News) - Peel Hunt initiated coverage on Avacta on Thursday with a 'buy' rating and 99p price target as it pointed out three key aspects of the investment case.
By Josh White
Date: Wednesday 20 Nov 2024
(Sharecast News) - London stocks ended Wednesday in negative territory as unexpectedly high UK inflation data dampened hopes of an imminent interest rate cut by the Bank of England.
Price | 19,430.33 |
Closing Price Change | 171.19 |
% Change | 0.89 % |
21-Nov-24 Close | 19,430.33 |
You are here: research